Johnson & Johnson
The European Commission announced that it has opened an antitrust investigation into arrangements between U.S. drug maker Johnson & Johnson and the generic division of Swiss-based Novartis.
Commission staff are looking...
Subscription required to view this article.
This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login
to access this content
If you do not currently subscribe to FTCWatch please contact us for subscription information:
FTCWatch is delivered in the following formats: via email alert and online at mlexwatch.com/ftcwatch